US EditionPublished • loading... • Updated
FDA Approves New Generic Abortion Pill as Lawsuit Moves to Missouri
The lawsuit challenges FDA rules on mifepristone, seeking to shorten the pregnancy limit from 10 to 7 weeks and require three in-person doctor visits, citing safety concerns and state law conflicts.
- The FDA has approved a new generic version of mifepristone, manufactured by Evita Solutions, which is approved for pregnancies up to ten weeks.
- U.S. District Judge Matthew Kacsmaryk transferred the abortion drug lawsuit from Texas to Missouri, allowing the anti-abortion medical coalition to continue their fight against mifepristone.
- Health and Human Services Secretary Robert F. Kennedy Jr. has announced a review of mifepristone's safety, responding to pressure from abortion opponents.
- Opposition from anti-abortion advocates has intensified, with statements condemning the FDA's actions as a betrayal of the pro-life movement, especially from figures like Former Vice President Mike Pence.
Insights by Ground AI
Podcasts & Opinions
193 Articles
193 Articles
Evita Solutions announced that the US FDA has approved their cheaper form of mifepristone, a pill for terminating pregnancies up to the tenth week.
This decision, which serves as a routine procedure, was strongly criticized by the president of the powerful anti-abortion association Students for Life Action.
·Paris, France
Read Full Article
The authorisation of a new generic of mifepristone in the United States revives the debate on access to abortion and provokes a strong reaction from conservative circles The American Agency for
·France
Read Full Article
Coverage Details
Total News Sources193
Leaning Left35Leaning Right46Center87Last UpdatedBias Distribution52% Center
Bias Distribution
- 52% of the sources are Center
52% Center
L 21%
C 52%
R 27%
Factuality
To view factuality data please Upgrade to Premium
